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Purpose: The purpose of this study was to characterize the osseointegration of the fibronectin-coated implant surface.
Methods: Sand-blasted, large-grit, acid-etched (SLA) surface implants, with or without a thin calcium phosphate and fibro-
nectin coating, were placed in edentulous mandibles of dogs 8 weeks after extraction. All dogs were sacrificed forhistological 
and histomorphometric evaluation after 4- and 8-week healing periods. 
Results: All types of implants were clinically stable without any mobility. Although the bone-to-implant contact and bone 
density of the SLA implants coated with calcium phosphate (CaP)/fibronectin were lower than the uncoated SLA implants, 
there were no significant differences between the uncoated SLA surface group and the SLA surface coated with CaP/fibronec-
tin group.
Conclusions: Within the limits of this study, SLA surfaces coated with CaP/fibronectin were shown to have comparable bone-
to-implant contact and bone density to uncoated SLA surfaces.
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INTRODUCTION
Surface modifications of titanium implants using various 
modalities aim to improve the initial healing and promote 
faster healing times [1]. With this surface modification, im-
mediate or early loading has become a predictable treatment 
protocol [2]. Sand-blasted, large-grit, acid-etched (SLA) surfac-
ing is one of these surface modifications. SLA surfacing has 
been shown to improve the clinical performance of implants 
[3,4]. Further modification of the SLA surface has been tested 
in an attempt to enhance implant stability [5,6].
Calcium phosphate (CaP) has bioactive and osteoconduc-
tive properties. It has been recognized that coating the sur-
face of titanium implants with CaP can help to achieve rapid 
fixation and spontaneous binding to the neighboring bone 
[7,8]. Biological apatite, which can improve bone healing, is 
deposited on the surface of CaP-coated implants after im-
plantation by the release of calcium and phosphate ions from 
the implant surface into the peri-implant region [8,9]. An ion-
beam-assisted deposition (IBAD) method has recently been 
shown to improve the bond strength of the CaP coating layer 
[10,11].
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Growth-factor-induced proliferation, differentiation, and 
migration have been shown to require the adhesion of cells 
to the extracellular matrix (ECM). Fibronectin, which is a ma-
jor ECM component, is used as a substrate for cell attachment 
[12]. The first biological reaction at the interface between the 
biomaterial and tissue after implantation is the adsorption of 
body fluid proteins onto its surface, and subsequent biologi-
cal responses at the interface are controlled by these adsorbed 
proteins [13,14]. The selective adsorption of beneficial mole-
cules has been attempted by modifying the implant surfaces. 
It has beendemonstrated that coating the surface with cell-
adhesive proteins, such as fibronectin, collagen, and/or lam-
inin, improved initial cell attachment, cell spreading, and cell 
activity [15-18].
It has recently been recognized that biomimetic coating 
methods can improve the biological performance of implants. 
It has been reported that bone-like apatite was formed through 
coating, which involved soaking biomaterials in a simulated 
body fluid with ion concentrations similar to those found in 
human blood plasma. Biologically active molecules can be 
deposited with inorganic components and incorporated into 
the crystal lattice [19]. Biomimetic coating with fibronectin 
has been tested in previous studies [20-23]. It is believed that 
application of fibronectin to the implant surface can enhance 
the osseointegration of dental implants to the bone [20-23]. 
Fibronectin is one of the cell-adhesive proteins that can im-
prove cell activity, initial cell attachment, and cell spreading, 
and it is actively involved in cytoskeletal reorganization and 
bone tissue formation, in part by regulating the survival of 
osteoblasts [24]. Fibronectin belongs to a group of high mo-
lecular weight glycoproteins that exist on cell surfaces. It is 
found in connective tissues, basement membranes, and ex-
tracellular fluids, and is known to play a role in cell-to-cell 
and cell-to-substrate adhesion [25], as well as an important 
role in osseointegration due to its capacity to make osteoblasts 
attach to ECM components. Furthermore, fibronectin has 
calcium-sensitive heparin-binding sites that should interfere 
with the biomineralization of titanium implants. Fibronectin 
adsorption onto solid substrates has already been evaluated 
in previous studies [26,27], though the interactions between 
this protein and biomaterial surfaces are not fully understood. 
Fibronectin is also known to enhance gingival fibroblast at-
tachment, which has beneficial effects on healing after im-
plant surgery and during the maintenance phase by forming 
attachments between connective tissue and the epithelium, 
which can prevent inflammatory breakdown around the im-
plant. In contrast to natural teeth, cementum - into which 
gingival fibers can insert - does not exist around dental im-
plants. Apical migration of the long junctional epithelium, 
which is the result of poor attachment between the subepi-
thelial connective tissues and the epithelium around the im-
plant, leads to the formation of peri-implant pockets. Inflam-
matory breakdown is caused by bacterial invasion through 
the peri-implant pocket [28,29]. The formation of a pocket 
around an implant can extend directly to the underlying bone 
in the absence of a transgingival seal between the gingival 
tissue and the implant. If this inflammatory breakdown ex-
tends to the underlying bone, the condition is defined as peri-
implantitis, and can lead to implant failure [28].
The purpose of this study was to determine the effect of 
coating the implant surface with fibronectin on osseointe-
gration.
MATERIALS AND METHODS
Animals
Four male, 18- to 24-month-old mongrel dogs weighing 
about 30 kg each were chosen. The dogs had intact dentition 
without any inflammation in the periodontium. The man-
agement, preparation, and surgical protocols used for the 
animals followed the standard protocols approved by the An-
imal Care and Use Committee of the Yonsei Medical Center, 
Seoul, Korea.
Sample preparation
SLA-surface-modified titanium implants (3.4 mm in diam-
eter and 8.0 mm in length; Implantium, Dentium, Seoul, Ko-
rea) were used as substrates. The control condition was im-
plantation of SLA-modified implants without fibronectin or 
CaP, while the experimental condition was implantation of 
SLA-modified implants that had been coated with a thin film 
of CaP, followed by fibronectin.
To prepare the Dulbecco’s phosphate-buffered saline (DPBS) 
solution containing DPBS fibronectin (DPBSF), DPBS (calci-
um/magnesium free, Gibco BRL, San Diego, CA, USA) and 
reagent-grade CaCl2 (100 mg/L) were dissolved in distilled 
water. Details of the procedures for incorporating fibronec-
tin into surfaces and deposition employed in this study have 
been described elsewhere [20]. Each SLA-surfaced implant 
coated with a thin film of CaP was immersed in 2.0 mL of 
DPBSF solution at 37°C for 24 hours. The fibronectin-incor-
porated implants were then rinsed twice with distilled water 
and then air dried at ambient temperature. All of the solu-
tions used were sterilized before use by filtration through a 
membrane with a pore size of 0.20 µm.
Study design
There were two groups separated by the surface condition 
of the implant (i.e., SLA- or fibronectin/CaP/SLA-surfaced). 
Healing was observed after 4 and 8 weeks. SLA-surfaced im-
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plants (n=8) were considered the control condition, and fi-
bronectin/CaP-coated SLA-surfaced implants (n=8) as the 
experimental condition.
Surgical protocol
Mandibular premolars were extracted under general anes-
thesia and sterile conditions. Atropine was injected subcuta-
neously at 0.05 mg/kg, and 2 mg/kg xylazine (Rompun, Bayer 
Korea Ltd, Seoul, Korea) and 10 mg/kg ketamine hydrochlo-
ride (Ketalar, Yuhan, Seoul, Korea) were administered intra-
venously. The dogs were laid on a heating pad during sur-
gery. An endotracheal tube was used for intubation, and an-
esthesia was maintained using 2% enflurane. The dogs were 
monitored with an electrocardiogram. After a 2-month heal-
ing period, 16 implants (8 SLA and 8 fibronectin-coated SLA) 
were placed into the edentulous mandibles as described be-
low.
The animals were anesthetized as described above. A crest-
al incision was made and a full mucoperiosteal flap was raised. 
Two implant sites were identified on each side of the mandi-
bles, and surgical preparation was performed according to 
the manufacturer’s instructions using pilot and twist drills. 
Postoperative care was similar to that for tooth extraction. 
The sutures were removed after 7 to 10 days, and the dogs 
were fed a soft diet for 2 weeks. The dogs were sacrificed with 
an anesthesia overdose after either 4 or 8 weeks of healing.
Clinical and histologic analysis
Block sections including the segments with implants were 
preserved. They were fixed in 10% neutral buffered formalin, 
dehydrated in ethanol, embedded in methacrylate, and sec-
tioned in the mesiodistal plane. The central section from each 
specimen was reduced to a 35-μm thickness by microgrind-
ing (Exakt, Norderstedt, Germany). The sections were stained 
with Goldner’s trichrome. Histologic evaluation was per-
formed under an optical microscope (Leica Microsystems 
Wetzlar GmbH, Wetzlar, Germany).
Histometric analysis
Computer-assisted histometric measurements were made 
with an automated image-analysis system (Image-Pro Plus, 
Media Cybernetics, Silver Spring, MD, USA). Bone density 
(BD) and bone-to-implant contact (BIC) were measured his-
tomorphometrically in the buccolingual plane. The percent-
age of BD in areas among the five coronal threads was calcu-
lated.
Statistical methods
Mann-Whitney testing was used to determine whether the 
mean values of BIC and BD differed significantly (α=0.01) 
between the groups at each healing time point.
RESULTS
Clinical and histologic analysis
All implants were clinically stable and non-mobile. The os-
seointegration of each implant was confirmed. Osteoblasts 
had actively deposited osteoid matrix on the implant surface. 
The newly formed bone in the interthread space was in close 
contact with the implant surface, without any gaps or dense 
fibrous connective tissue. No apical epithelial migration was 
found. No inflammatory cell infiltrate was present around 
the implants. A few areas of bone remodeling with osteoblasts 
and osteoid matrix were observed.
Four-week time point
Fibronectin coating SLA group 
Implants were stable without any mobility. The bone tissue 
surrounding implants is shown in Fig. 1. A greater amount of 
osteoid matrix (arrow), which is the unmineralized organic 
portion of bone matrix, was observed than uncoated SLA 
group. Newly formed bone which affected BIC and BD was 
also found in the interthread space. 
SLA Group 
Implants were stable without any mobility. The bone tissue 
surrounding implants is shown in Fig. 2. Osteoid matrix was 
also observed. A thin lining of newly formed bone was ob-
served on the implant surface. Marrow space (arrow) near the 
osteoid matrix was observed. The amount of newly formed 
bone in the interthread space was less than for the other 
group.
Figure 1. Histologic view of the fibronectin-coated sandblasted, 
large-grit, acid-etched group at 4 weeks (Goldner’s trichrome stain-
ing, ×40). Osteoid matrix (arrow) and newly formed mineralized 
bone in the interthread space were observed.
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Eight-week time point
Fibronectin coating SLA group
Implants were stable without any mobility. The bone tissue 
surrounding implants is shown in Fig. 3. Osseointegration of 
each implant was confirmed. Anincreased amount of newly 
formed mineralized bone in the interthread space was ob-
served when compared with the 4-week fibronectin coated 
SLA group. 
SLA group 
Implants were stable without any mobility. The bone tissue 
surrounding implants is shown in Fig. 4. Osseointegration of 
each implant was confirmed. The newly formed bone in the 
interthread space was in close contact with the implant sur-
face without any gaps or dense fibrous connective tissue. No 
apical epithelial migration was found. No inflammatory cell 
infiltrate was present around the implants. Anincreased 
amount of newly formed mineralized bone in the interthread 
space was observed when compared with the 4-week SLA 
group. 
Histometric analysis 
The mean values of BIC and BD were lower in the fibro-
nectin/CaP-coated SLA group than in the SLA group after 
both 4 and 8 weeks of healing. The mean values of BIC and 
BD in both groups (fibronectin/CaP-coated SLA and SLA) 
were lower after 4 weeks of healing than at 8 weeks (Table 1). 
BIC and BD did not differ significantly between the groups.
DISCUSSION
The aim of the present study was to characterize the osseo-
integration of fibronectin/CaP-coated SLA-modified titani-
um dental implants. The BIC and BD of the coated implants 
were not greater than those of SLA implants without the fi-
Figure 2. Histologic view of the sandblasted, large-grit, acid-etched 
group at 4 weeks (Goldner’s trichrome staining, ×40). A thin lining 
of newly formed bone was observed on the implant surface. Mar-
row space (arrow) near the osteoid matrix was observed.
Figure 4. Histologic view of the sandblasted, large-grit, acid-etched 
group at 8 weeks (Goldner’s trichrome staining, ×40). The newly 
formed bone in the interthread space was in close contact with im-
plant surface without any gaps or dense fibrous connective tissue. 
No apical epithelial migration was found. No inflammatory cell in-
filtrate was present around the implants. 
Figure 3. Histologic view of the fibronectin-coated sandblasted, 
large-grit, acid-etched group at 8 weeks (Goldner’s trichrome stain-
ing, ×40). Osseointegration of each implant was confirmed. Newly 
formed mineralized bone in the interthread space was observed. 
Table 1. Bone-to-implant contact and bone density after 4 and 8 
weeks of healing for sandblasted, large-grit, acid-etched (SLA)- and 
fibronectin/calcium phosphate (CaP)-coated SLA-surfaced titanium 
implants (SLA fibronectin/CaP).
Healing 
time Group
Bone-to-implant 
contact (%) Bone density (%)
4 weeks SLA 70.1±14.4 54.1±18.7
SLA fibronectin/CaP 52.9±11.7 43.4±18.1
8 weeks SLA 70.1±17.1 59.2±21.2
SLA fibronectin/CaP 54.7±17.6 53.9±16.7
Values are presented as mean±SD.
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bronectin and CaP coating. Although the fibronectin/CaP 
coating of the SLA implant surface did not enhance osseoin-
tegration, it did not adversely affect healing in this canine 
study. There are several possible reasons for this, as discussed 
below.
Firstly, the canine model used in the present study was prob-
ably not sufficient to reveal any differences. The site prepara-
tion was performed according to the manufacturer’s recom-
mendations, without any defects. The SLA implants were 
coated with fibronectin after the surface had first been coat-
ed with a thin layer of CaP using the IBAD method, in which 
the original surface roughness is retained after coating. In a 
previous study using SLA implants coated with a thin layer of 
CaP to restore self-contained coronal defects in dogs, BIC 
and BD values that can be considered to reflect enhanced os-
seointegration were greater for SLA implants coated with a 
thin layer of CaP than for standard SLA implants [6]. In addi-
tion, a previous in vitro study with titanium discs coated with 
a thin layer of CaP followed by fibronectin found that the fi-
bronectin that became incorporated into the apatite deposit-
ed on the surface of the titanium did not affect its biological 
activity in terms of promoting osteoblast attachment [20]. 
Therefore, in the present study, the fibronectin/CaP coating 
of SLA-modified titanium dental implants was expected to 
enhance osseointegration because 1) it had surface rough-
ness, 2) a thin coating of CaP had already been shown to en-
hance osseointegration, and 3) a fibronectin coating has been 
shown to promote osteoblast attachment. However, enhanced 
osseointegration was not found in our canine model. Two 
osteogenetic phenomena have been proposed to occur around 
dental implants: distance and contact osteogenesis [30]. Dis-
tance osteogenesis takes place on the surface of the bone 
around the implant through appositional growth, while con-
tact osteogenesis occurs directly on the surface of the implant. 
Contact osteogenesis was found to be enhanced more by a 
rough implant surface than by a smooth implant surface due 
to the increased surface area available for fibrin attachment 
and surface features to which fibrin could become attached. 
It is possible that fibronectin-coated SLA implants exhibit 
enhanced osseointegration in self-contained coronal defects 
in dogs because fibronectin has the ability to promote osteo-
blast attachment more via distance osteogenesis.
Secondly, it is not clear whether or not fibrin-coated fibro-
nectin molecules preserve cell-adhesive activity after surgery. 
If the bond between the fibronectin coating and the sub-
strate is not strong enough, the coating surface maybe exfoli-
ated during surgery. Further study is necessary to examine 
changes in the cellular activity of cultured cells on the fibro-
nectin-coated implant surface.
Thirdly, the healing period might not have been short 
enough to reveal any differences in healing due to coating 
the surfaces. Fibronectin affects healing in the early healing 
period. It may be that a difference would have been revealed 
if the healing had been evaluated after only 2 weeks. Future 
studies should examine the effects of applying a fibronectin-
coated implant on early healing. In addition, the influence of 
fibronectin-coating SLA implants on long-term prognosis 
should be evaluated clinically. In particular, changes in soft-
tissue healing, which can affect the long-term prognosis of 
implant therapy, should be evaluated. More rapid and en-
hanced soft-tissue healing around the implant may occur as 
a result of enhancement of epithelial cell attachment, spread-
ing, and hemidesmosome assembly affected by the fibronec-
tin coating applied to SLA implants. A canine model should 
be used to evaluate soft-tissue healing. In conclusion, the BD 
and BIC of fibronectin-coated implants were comparable to 
those of SLA-surfaced implants, which have been proven to 
be one of the most predictable implant types.
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